Estimating Costs in the Economic Evaluation of Medical Technologies

No abstract is available for this paper.

• Publication year

  1990

• Venue

  International Journal of Technology Assessment in Health Care

• Publication date

  1990-01-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1017/S026646230000893XPMID 2113891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An analysis of the cost effectiveness of the implantable defibrillator.

  1990cited by this paper
• Economic evaluation in the development of medicines: by Michael Drummond, George Teeling Smith and Nicholas Wells. Office of Health Economics, London, 1988. 36 pp. No price given

  1989cited by this paper
• Economical appraisal of health technology in the European Community

  1988cited by this paper
• Economic appraisal of health technology in the european community: by M.F. Drummond (Ed.) Oxford University Press, Oxford, 1987 265 pp., ISBN 0-19-261634-X, [pound sign]30.00

  1988cited by this paper
• Evaluating Preventive Care

  1988cited by this paper
• Measuring the economic impact of perioperative total parenteral nutrition: principles and design.

  1988cited by this paper
• Cost-effectiveness of combined treatment for endocervical gonorrhea. Considering co-infection with Chlamydia trachomatis.

  1987cited by this paper
• Economics in hypertension management: cost and quality trade-offs.

  1987cited by this paper
• Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.

  1987cited by this paper
• Prevention of venous thromboembolism after general surgery. Cost-effectiveness analysis of alternative approaches to prophylaxis.

  1987cited by this paper
• CLINICAL PHARMACOKINETICS, TOXICITY AND COST EFFECTIVENESS ANALYSIS OF AMINOGLYCOSIDES AND AMINOGLYCOSIDE DOSING SERVICES

  1987cited by this paper
• Applications of cost-benefit analysis to health care. Departures from welfare economic theory.

  1987cited by this paper
• The cost-effectiveness of three smoking cessation programs.

  1987cited by this paper
• Economics in hypertension management: cost and quality trade-offs.

  1987cited by this paper
• Cost-effectiveness of Combined Treatment for Endocervical Gonorrhea: Considering Co-infection With Chlamydia trachomatis

  1987cited by this paper
• Guidelines for the clinical and economic evaluation of health care technologies.

  1986cited by this paper
• Cost-effective choice of antimicrobial therapy for serious infections

  1986cited by this paper
• Economic aspects of risk assessment in chemical safety.

  1986cited by this paper
• A Cost-effectiveness Analysis of Cyclosporine in Cadaveric Kidney Transplantation

  1986cited by this paper
• A multicenter study of annual health service utilization and costs in rheumatoid arthritis.

  1986cited by this paper
• Cost‐Effectiveness of Fine Needle Biopsy of the Breast

  1986cited by this paper
• Competing technologies. Implications for the costs and complexity of medical care.

  1986cited by this paper
• Savings from outpatient antibiotic therapy for osteomyelitis. Economic analysis of a therapeutic strategy.

  1986cited by this paper
• Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy.

  1986cited by this paper
• Cost-benefit and cost-effectiveness analysis of drug therapy.

  1985cited by this paper
• Cost-Effectiveness of Coronary Artery Bypass Surgery

  1985cited by this paper
• Artificial heart and assist devices: directions, needs, costs, societal and ethical issues.

  1985cited by this paper
• Cost-effectiveness of interventions to prevent or treat coronary heart disease.

  1985cited by this paper
• Willingness to pay for reduction in fatality risk: an exploratory survey.

  1984cited by this paper
• New drugs and clinical economics: analysis of cost effectiveness in the assessment of pharmaceutical innovations.

  1984cited by this paper
• Cost-Benefit and Cost-Effectiveness Analysis in Health Care: Principles, Practice, and Potential

  1984influential reference
• COST EFFECTIVENESS IN A HOSPITAL CONTACT LENS DEPARTMENT

  1984cited by this paper
• Cost-effectiveness of antepartum prevention of Rh immunization.

  1984cited by this paper
• Economic evaluation of neonatal intensive care of very-low-birth-weight infants.

  1983cited by this paper
• Cost–effectiveness of Coronary Artery Bypass Surgery

  1982cited by this paper
• The distinction between cost and charges.

  1982cited by this paper
• Cost-of-illness methodology: a guide to current practices and procedures.

  1982cited by this paper
• Principles of Economic Appraisal in Health Care

  1981cited by this paper
• Evaluation of neonatal-intensive-care program.

  1981cited by this paper
• Modeling the effectiveness and cost-effectiveness of an emergency service system.

  1981cited by this paper
• Cost-benefit analysis versus cost-effectiveness analysis for the evaluation of long-term care programs.

  1981cited by this paper
• The Implications of Cost-Effectiveness Analysis of Medical Technology. Background Paper No. 4: The Management of Health Care Technology in Ten Countries

  1981cited by this paper
• Alternative to mental hospital treatment. II. Economic benefit-cost analysis.

  1980cited by this paper
• Allocation of Resources to Manage Hypertension

  1977cited by this paper
• Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension.

  1977cited by this paper
• Foundations of cost-effectiveness analysis for health and medical practices.

  1977influential reference
• The swine-influenza decision.

  1976cited by this paper
• Procedures for valuing lives.

  1975cited by this paper

• Comparative Cost-Effectiveness of Two Artificial Liver Therapies in Early-Stage Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Retrospective Cohort Study

  2025cites this paper
• Methodology of economic evaluations in spine surgery: a systematic review and qualitative assessment

  2023cites this paper
• Value Insider Season 1 Episode 4: How are Costs Measured, and How are CEAs Constructed and Used? (CEA) [Podcast]

  2022cites this paper
• Implementation costs of a community health worker delivered weight loss intervention in black churches serving underserved communities

  2020cites this paper
• Improving the estimation of patient costs due to TB

  2019cites this paper
• Review of economic analyses of treatment for non-small–cell lung cancer (NSCLC)

  2018cites this paper
• The true cost of epidemic and outbreak diseases in hospitals

  2018cites this paper
• Pharmacoéconomie pour le pneumologue : l’exemple des cancers pulmonaires

  2018cites this paper
• Health economics and quality of life in a feasibility RCT of paediatric acute appendicitis: a protocol study

  2018cites this paper
• Costing Psychiatric Hospitals and Psychiatric Wards in General Hospitals

  2017cites this paper
• Economic Burden of Herpes Zoster ("culebrilla") in Latin America.

  2017cites this paper
• Health technology assessment of hyperphosphatemia management among hemodialysis patients in Lebanon

  2017cites this paper
• Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial

  2017cites this paper
• Methods for Measuring and Estimating Costs

  2017cites this paper
• Mental Health Economics

  2017influential citation
• Antihypertensive use, prescription patterns, and cost of medications in a Teaching Hospital in Lagos, Nigeria.

  2016cites this paper
• Economic evaluations in healthcare

  2015cites this paper
• Risk of bias in trial-based economic evaluations: Identification of sources and bias-reducing strategies

  2015cites this paper
• Efficiency and Variance Reduction

  2015cites this paper
• Designing for value, using analytics of medical device field data

  2014cites this paper
• Economic Evaluation of Cervical Cancer Screening: Are Costs Outside Health Care Included?

  2014cites this paper
• Inter-sectoral costs and benefits of mental health prevention: towards a new classification scheme.

  2013cites this paper
• The societal cost of bipolar disorder in Sweden

  2013cites this paper
• Medical technology as a key driver of rising health expenditure: disentangling the relationship

  2013cites this paper
• The economic burden of visual impairment and blindness: a systematic review

  2013cites this paper
• Analytic approaches for informing research funding decisions : an exploration of their role and value using case studies of cancer clinical trials

  2013cites this paper
• Guidelines for the economic analysis of a telematic platform for Parkinson's disease monitoring

  2013cites this paper
• The societal cost of depression: evidence from 10,000 Swedish patients in psychiatric care.

  2013cites this paper
• The cost of headache disorders in Europe: the Eurolight project

  2012cites this paper
• Tipos de Cos Tes a in Cluir en una evalua Ción eConómi Ca

  2012cites this paper
• Tipos de costes a incluir en una evaluación económica

  2012cites this paper
• Economic Evaluations of Type II Diabetes

  2012cites this paper
• The effect of cost construction based on either DRG or ICD-9 codes or risk group stratification on the resulting cost-effectiveness ratios

  2012cites this paper
• Socioeconomic Evaluation in Medicine in Europe

  2012cites this paper
• Costos de enfermedades: Una revisión crítica de las metodologías de estimación

  2012cites this paper
• A Simulation Model for Estimating Direct Costs of Type 1 Diabetes Prevention

  2012cites this paper
• Economic issues associated with the operation and evaluation of telemedicine

  2011cites this paper
• [Cost-of-illness in systemic sclerosis: a retrospective study of an Italian cohort of 106 patients].

  2011cites this paper
• Synthesizing Economic Evidence

  2011influential citation
• Pharmacoéconomie pour le pneumologue

  2010cites this paper
• Costs of HIV Prevention among Out-of-Treatment Drug-Using Women: Results of a Randomized Controlled Trial

  2010cites this paper
• Simulation of the costs and consequences of potential vaccines for Plasmodium falciparum malaria

  2010cites this paper
• A guide to interpreting economic studies in infectious diseases.

  2010cites this paper
• Technological and socio-economic implications in the development of implantable drug infusion systems for cancer therapy in tricky anatomic compartments: the case of brain tumours

  2010cites this paper
• Identifying unit costs for use in regional economic evaluation: an illustrative analysis of childhood pneumococcal conjugate vaccine in Latin America and the Caribbean.

  2009cites this paper
• Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women

  2009cites this paper
• Simulation of the cost-effectiveness of malaria vaccines

  2009cites this paper
• Small and Medium‐Sized Congenital Nevi in Children: A Comparison of the Costs of Excision and Long‐Term Follow‐Up

  2009cites this paper
• COST ANALYSIS AND POLICY IMPLICATIONS IN PSYCHIATRIC CARE

  2009cites this paper
• Long term success of a telehealth network : a case study of the upper peninsula telehealth network

  2009cites this paper
• Economic Evaluation of Environmental Health Interventions to Support Decision Making

  2008influential citation
• The future health (care) burden of chronic diseases in the Netherlands

  2008cites this paper
• Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors

  2008cites this paper
• Health care cost containment

  2008cites this paper
• Costs of disorders of the brain in Europe

  2007cites this paper
• The economic burden of depression in Sweden from 1997 to 2005

  2007cites this paper
• Estimation of the cost of MS in Europe: Extrapolations from a multinational cost study

  2007cites this paper
• Comparative analysis of two alternative models for epidemiological surveillance in the Mexican Malaria Control Program.

  2007cites this paper
• The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania.

  2006cites this paper
• Economic implications of nonadherence to highly active antiretroviral treatment in HIV patients

  2006cites this paper
• Health economics of depression

  2006cites this paper
• Modeling and Uncertainty in Cost-effectiveness Analyses of Sepsis Therapies

  2006cites this paper
• Burden of Illness of Chronic Low Back Pain in Sweden: A Cross-Sectional, Retrospective Study in Primary Care Setting

  2005cites this paper
• Introducing economic evaluation as a policy tool in Korea: Will decision makers get quality information?

  2005cites this paper
• Cost of disorders of the brain in Europe

  2005cites this paper
• The main methodological issues in costing health care services: A literature review

  2005cites this paper
• A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.

  2005cites this paper
• The economic cost of low back pain in sweden in 2001

  2005cites this paper
• Integrating ethical enquiry and health technology assessment: limits and opportunities for efficiency and equity

  2004cites this paper
• Cost-Effectiveness of Lumbar Fusion and Nonsurgical Treatment for Chronic Low Back Pain in the Swedish Lumbar Spine Study: A Multicenter, Randomized, Controlled Trial From the Swedish Lumbar Spine Study Group

  2004cites this paper
• Economic evidence in epilepsy: a review

  2004cites this paper
• Cost analysis in telemedicine: empirical evidence from sites in Arizona.

  2004cites this paper
• Farmacoeconomía: Lo esencial del análisis economico en el cuidado de la salud

  2004cites this paper
• The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome.

  2004cites this paper
• Economic evidence in stroke: a review

  2004cites this paper
• Economic evidence in stroke: a review

  2004cites this paper
• International Comparison of Stroke Cost Studies

  2004cites this paper
• Evidence from cost-effectiveness research

  2004cites this paper
• Critical Review of health care economic evaluation methodology : With a special reference to study design and cost estimation

  2004cites this paper
• Evidence from cost-effectiveness research

  2004cites this paper
• Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen

  2003cites this paper
• Economic evidence for evidence-based practice.

  2002cites this paper
• ALUATION OF GOODS IN COST-EFFECTIVENESS ANALYSIS : NOTIONS OF OPPORTUNITY COSTS AND TRANSFERABILITY ACROSS TIME AND COUNTRIES

  2002cites this paper
• Issues in pooling administrative data for economic evaluation.

  2002cites this paper
• A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000.

  2002cites this paper
• Health Economics: An Introduction to Economic Evaluation

  2002cites this paper
• Pooling multisite administrative data for economic analysis

  2002cites this paper
• Cost Effectiveness of Antibacterial Restriction Strategies in a Tertiary Care University Teaching Hospital

  2001cites this paper
• [Economic evaluation of eptifibatide].

  2001cites this paper
• Estimating the Costs of Epilepsy: An International Comparison of Epilepsy Cost Studies

  2001cites this paper
• Economic Evaluation in Stroke Research

  2001cites this paper
• Economic aspects of caesarean section and alternative modes of delivery.

  2001cites this paper
• Current Practice and Suggestions for Improvement

  2001cites this paper
• Resource utilization and cost of rheumatic fever.

  2001cites this paper
• Evaluación económica de eptifibatide

  2001cites this paper
• Implementing the Philosophy of Pharmaceutical Care into Community Pharmacy Services - Experiences with Asthma Patients in Finland

  2001cites this paper
• Pharmaceutical Technology Assessment for Managed Care: Current Practice and Suggestions for Improvement

  2001cites this paper
• P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia

  2000cites this paper
• A cost-benefit analysis using a willingness-to-pay questionnaire of intranasal budesonide for seasonal allergic rhinitis. Rhinocort Study Group.

  2000cites this paper
• Cost estimates for hospital inpatient care in Australia: evaluation of alternative sources

  2000cites this paper